Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lift Therapeutics logo — A New Direction in Immunology

Lift Therapeutics

A New Direction in Immunology

Founded 2016 United Kingdom London, United Kingdom 24 employees

General Information

Company Name Lift Therapeutics
Founded Year 2016
Location United Kingdom London, United Kingdom +1
Employees 24
Social

Get notified when Lift Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Key Hire Sep 23, 2026

Lift Therapeutics announced the appointment of Daniel Passeri as their new Chief Executive Officer. He previously served as CEO of Cue Biopharma.

Key Exit Sep 23, 2026

Bo Rode Hansen is stepping down from his role as Interim CEO at Lift Therapeutics. He will resume his role as a member of the Board of Directors and assume the role of President.

Get alerts when Lift Therapeutics shows new signals

About Lift Therapeutics

Lift Therapeutics is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno-Modulatory Alpha Neutrophils (iMANs). Our proprietary, platform harnesses neutrophils’ innate tumour-homing and infiltrating attributes, combined with their ability to directly kill cancer cells and safely orchestrate broader immune responses, offering a powerful and antigen-independent treatment option to overcome cancer resistance mechanisms, like suppressive tumour environment and immune evasion. Backed by deep neutrophil biology expertise and a scalable manufacturing platform, Lift is advancing a differentiated pipeline with application across multiple solid cancers.

No funding data available for Lift Therapeutics yet.

Get notified when Lift Therapeutics raises funding

Latest News

View All
LIfT BioSciences lands record €12M grant to launch human cancer trials — Tech
LIfT BioSciences lands record €12M grant to launch human cancer trials
Tech Jul 29, 2025
London-based LIfT BioSciences secures €12 million to ovecome treatment resistance in solid tumours — Eu-startups
London-based LIfT BioSciences secures €12 million to ovecome treatment resistance in solid tumours
Eu-startups Jul 29, 2025
Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments — Eu-startups
Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments
Eu-startups Oct 06, 2025
LIfT BioSciences is engineering the body’s oldest defenders to fight cancer — Tech
LIfT BioSciences is engineering the body’s oldest defenders to fight cancer
Tech Oct 07, 2025
French startup Exeliom Biosciences boosts funding with €2.85 million to accelerate immunotherapy for... — Eu-startups
French startup Exeliom Biosciences boosts funding with €2.85 million to accelerate immunotherapy for cancer
Eu-startups Oct 21, 2025
€10.3 million boost for Sweden’s Cellcolabs to lower global stem cell costs by 90% through scalable... — Eu-startups
€10.3 million boost for Sweden’s Cellcolabs to lower global stem cell costs by 90% through scalable manufacturing
Eu-startups Oct 27, 2025

Lift Therapeutics Alternatives & Competitors

Lift Therapeutics vs
Currus Biologics Pty Ltd
Currus Biologics Pty Ltd Australia

Currus Biologics is developing its proprietary BEAT technology to treat solid tumours.

Series Unknown
6 employees
Biotechnology, Health and Wellness
Lift Therapeutics vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post Ipo Equity
14 employees
Biopharma, Biotechnology
Lift Therapeutics vs
Cartherics Pty Ltd
Cartherics Pty Ltd Australia

Rearming the body’s immune system to fight cancer

Undisclosed
35 employees
Biotechnology

FAQ About Lift Therapeutics

A New Direction in Immunology
Lift Therapeutics was founded in 2016.
Lift Therapeutics is headquartered in London, United Kingdom.
Lift Therapeutics has approximately 24 employees.
Top alternatives and competitors to Lift Therapeutics include Currus Biologics Pty Ltd, Prescient Therapeutics, Cartherics Pty Ltd, Link Cell Therapies, GO Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lift Therapeutics and Currus Biologics Pty Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Lift Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes